HIT HGG 2013 International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013) (Aktiv)
LOGGIC/FIREFLY-2 LOGGIC/Firefly-2: A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy (Aktiv)
ONC201-108 ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study (Aktiv)